During the past decade, Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 91 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 64 trials, followed by "Radiation Therapy Oncology Group" with 37 trials sponsored, "Children's Oncology Group" with 36 trials sponsored, "Gynecologic Oncology Group" with 11 trials sponsored and "SWOG Cancer Research Network" with 11 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis" #1 collaborator was "National Cancer Institute (NCI)" with 183 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Eastern Cooperative Oncology Group" with 6 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis" are "Lymphoma" (33 trials), "Leukemia" (23 trials), "Lung Cancer" (19 trials), "Breast Cancer" (18 trials) and "Prostate Cancer" (17 trials). Many other conditions were trialed in "Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis" in a lesser frequency.

Most popular intervention types in "Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis" are "Drug" (133 trials), "Radiation" (65 trials), "Biological" (59 trials), "Procedure" (57 trials) and "Other" (34 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (31 trials), "cyclophosphamide" (26 trials), "filgrastim" (23 trials), "cisplatin" (18 trials) and "doxorubicin hydrochloride" (18 trials). Other intervention names were less common.

The vast majority of trials in "Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis" are 143 trials for "All" genders, 28 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are NaN active trials in "Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis". undefined are not yet recruiting, undefined are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 149 completed trials in Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, 12 "Phase 1" clinical trials were conducted, 91 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".